ChemicalBook >> CAS DataBase List >>SB 225002

SB 225002

CAS No.
182498-32-4
Chemical Name:
SB 225002
Synonyms
SB 225002;SB-225002;SB 225002;SB 225002 USP/EP/BP;SB225002 182498-32-4;SB 225002 - CAS 182498-32-4 - Calbiochem;1-(2-bromophenyl)-3-(2-hydroxy-4-nitrophenyl)urea;N-(2-BROMOPHENYL)-N'-(2-HYDROXY-4-NITROPHENYL)UREA;N-(2-HYDROXY-4-NITROPHENYL)-N'-(2-BROMOPHENYL)UREA;Urea, N-(2-bromophenyl)-N'-(2-hydroxy-4-nitrophenyl)-
CBNumber:
CB1455331
Molecular Formula:
C13H10BrN3O4
Molecular Weight:
352.14
MDL Number:
MFCD00954637
MOL File:
182498-32-4.mol
Last updated:2023-07-12 16:39:50

SB 225002 Properties

Boiling point 401.6±45.0 °C(Predicted)
Density 1.793±0.06 g/cm3(Predicted)
storage temp. room temp
solubility Soluble to 100mM in DMSO and to 50mM in ethanol
form Yellow solid
pka 5.29±0.10(Predicted)
color white to beige
Sensitive Moisture Sensitive
Stability Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
InChIKey MQBZVUNNWUIPMK-UHFFFAOYSA-N
CAS DataBase Reference 182498-32-4

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H315-H319-H335
Precautionary statements  P261-P280a-P304+P340-P305+P351+P338-P405-P501a
Hazard Codes  Xi
Risk Statements  36/37/38
Safety Statements  26
WGK Germany  3
HS Code  2921490090
NFPA 704
0
2 0

SB 225002 price More Price(39)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML0716 SB 225002 ≥98% (HPLC) 182498-32-4 5mg $119 2024-03-01 Buy
Sigma-Aldrich 559405 SB 225002 182498-32-4 1mg $113 2024-03-01 Buy
TCI Chemical B6055 SB 225002 182498-32-4 10MG $163 2024-03-01 Buy
TCI Chemical B6055 SB 225002 182498-32-4 50MG $541 2024-03-01 Buy
Alfa Aesar J65387 SB 225002 182498-32-4 10mg $274 2023-06-20 Buy
Product number Packaging Price Buy
SML0716 5mg $119 Buy
559405 1mg $113 Buy
B6055 10MG $163 Buy
B6055 50MG $541 Buy
J65387 10mg $274 Buy

SB 225002 Chemical Properties,Uses,Production

Description

CXCR2 (IL-8RB) is a seven-transmembrane G protein-coupled receptor whose physiological ligands include IL-8 (CXCL8) and growth related oncogene α (Gro-α; CXCL1). IL-8 and Gro-α are pro-inflammatory CXC chemokines that act as chemoattractants, especially for neutrophils, and promote angiogenesis. SB 225002 is a selective non-peptide inhibitor of CXCR2, inhibiting IL-8 binding to CXCR2 with an IC50 value of 22 nM. SB225002 inhibits neutrophil chemotaxis in response to IL-8 in vitro (IC50 = 20 nM) and blocks neutrophil margination induced by IL-8 in vivo (IC50 = 30 nM). Similarly, SB 225002 reduces neutrophil influx, the production of inflammatory mediators, and tissue damage in TNBS-induced colitis in mice.

Uses

SB 225002 is a potent and selective CXCR2 antagonist with the ability to inhibit interleukin IL-8 binding to CXCR2.

Definition

ChEBI: 1-(2-bromophenyl)-3-(2-hydroxy-4-nitrophenyl)urea is a nitrophenol.

Biological Activity

Potent and selective CXCR2 chemokine receptor antagonist (IC 50 = 22 nM) that displays > 150-fold selectivity over CXCR1 receptors. Causes inhibition of IL-8 and GRO α -mediated calcium mobilization in HL60 cells (IC 50 values are 8 and 10 nM respectively). Prevents IL-8-induced neutrophil chemotaxis in vitro and sequestration in vivo . Inhibits HIV replication in lymphocytes and macrophages.

Biochem/physiol Actions

SB-225002 is a potent nonpeptide inhibitor of chemokine receptor CXCR2 with an IC50 of 22 nM for inhibiting interleukin IL-8 binding to CXCR2 and > 150-fold selectivity over CXCR1 receptors. CXCR2 binds many different immune cell chemoattractants. SB-225002 is crucial for cancer progression and is involved in inflammatory diseases like COPD, rheumatoid arthritis, and ulcerative colitis.

storage

Store at RT

References

1) White et al. (1998), Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration; J. Biol. Chem. 273 10095 2) Du et al. (2013) SB225002 Promotes Mitotic Catastrophe in Chemo-Sensitive and -Resistant Ovarian Cancer Cells Independent of p53 Status In Vitro; PLoS One. 8 e54572 3) Shen et al. (2013), Interleukin-8 prevents oxidative stress-induced human endothelial cell senescence via telomerase activation; Int. Immunopharmacol. 16 261 4) Lane et al. (2001), Interleukin-8 Stimulates Human Immunodeficiency Virus Type 1 Replication and Is a Potential New target for Antiretroviral Therapy; J. Virol. 75 8195 5) Wu et al. (2015), CXCR2 is essential for cerebral endothelial activation and leukocyte recruitment during neuroinflammation; J. Neuroinflammation 12 98

SB 225002 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 129)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
Accela ChemBio Inc.
(+1)-858-699-3322 info@accelachem.com United States 19965 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
Career Henan Chemica Co
+86-0371-86658258 15093356674; laboratory@coreychem.com China 30255 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6313 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 29322 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6393 58
Coresyn Pharmatech Co., Ltd.
+86-571-86626709 +86-18157142896 cbc@coresyn.com China 9991 58
ShenZhen Trendseen Biological Technology Co.,Ltd.
13417589054 trendseenbio@gmail.com China 11681 58
LEAPCHEM CO., LTD.
+86-852-30606658 market18@leapchem.com China 43348 58

SB 225002 Spectrum

SB 225002 N-(2-HYDROXY-4-NITROPHENYL)-N'-(2-BROMOPHENYL)UREA N-(2-BROMOPHENYL)-N'-(2-HYDROXY-4-NITROPHENYL)UREA 1-(2-bromophenyl)-3-(2-hydroxy-4-nitrophenyl)urea SB 225002 - CAS 182498-32-4 - Calbiochem SB-225002;SB 225002 Urea, N-(2-bromophenyl)-N'-(2-hydroxy-4-nitrophenyl)- SB 225002 USP/EP/BP SB225002 182498-32-4 182498-32-4 18298-32-4 Inhibitors A potent, selective, and competitive antagonist of the G-protein coupled receptor CXCR2. Antineoplastic